Ch. Rousselle

503 total citations
16 papers, 231 citations indexed

About

Ch. Rousselle is a scholar working on Health, Toxicology and Mutagenesis, Pulmonary and Respiratory Medicine and Cognitive Neuroscience. According to data from OpenAlex, Ch. Rousselle has authored 16 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Health, Toxicology and Mutagenesis, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Cognitive Neuroscience. Recurrent topics in Ch. Rousselle's work include Effects and risks of endocrine disrupting chemicals (3 papers), Carcinogens and Genotoxicity Assessment (2 papers) and Chemical Safety and Risk Management (2 papers). Ch. Rousselle is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (3 papers), Carcinogens and Genotoxicity Assessment (2 papers) and Chemical Safety and Risk Management (2 papers). Ch. Rousselle collaborates with scholars based in France, Sweden and Netherlands. Ch. Rousselle's co-authors include M David, V. des Portes, J.M. Scherrmann, Florence Ménétrier, É. Ansoborlo, C. Mottolèse, P. Berlier, Michael C. Burger, Karine Ostrowsky and Anna Beronius and has published in prestigious journals such as Toxicology and Applied Pharmacology, Toxicology Letters and Epilepsy & Behavior.

In The Last Decade

Ch. Rousselle

14 papers receiving 224 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ch. Rousselle France	7	71	55	32	30	27	16	231
M SIDDIQUI United Kingdom	7	53 0.7×	17 0.3×	76 2.4×	18 0.6×	11 0.4×	15	291
Yuto Suzuki Japan	12	27 0.4×	31 0.6×	46 1.4×	35 1.2×	19 0.7×	50	351
Sara Shepherd United States	9	41 0.6×	60 1.1×	9 0.3×	53 1.8×	43 1.6×	11	368
Anne Grüber France	8	91 1.3×	9 0.2×	6 0.2×	24 0.8×	20 0.7×	10	447
Samir N. Kelada United States	9	143 2.0×	40 0.7×	17 0.5×	99 3.3×	25 0.9×	10	529
A Guiet‐Bara France	11	20 0.3×	15 0.3×	10 0.3×	22 0.7×	50 1.9×	58	373
R. Besser Germany	10	82 1.2×	49 0.9×	29 0.9×	70 2.3×	15 0.6×	37	365
G Devathasan Singapore	8	78 1.1×	11 0.2×	29 0.9×	32 1.1×	19 0.7×	15	303
Eleonora Loi Italy	10	54 0.8×	36 0.7×	112 3.5×	27 0.9×	15 0.6×	19	457
Hiroko Nomura Japan	12	28 0.4×	37 0.7×	5 0.2×	36 1.2×	72 2.7×	46	378

Countries citing papers authored by Ch. Rousselle

Since Specialization

Citations

This map shows the geographic impact of Ch. Rousselle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ch. Rousselle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ch. Rousselle more than expected).

Fields of papers citing papers by Ch. Rousselle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ch. Rousselle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ch. Rousselle. The network helps show where Ch. Rousselle may publish in the future.

Co-authorship network of co-authors of Ch. Rousselle

This figure shows the co-authorship network connecting the top 25 collaborators of Ch. Rousselle. A scholar is included among the top collaborators of Ch. Rousselle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ch. Rousselle. Ch. Rousselle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Bodin, L., et al.. (2024). Opinion on the safety of alpha-arbutin and beta-arbutin in cosmetic products. SPIRE - Sciences Po Institutional REpository.

Gaffet, Éric, Ulrike Bernauer, Laurent Bodin, et al.. (2024). SCCS Scientific Advice on Titanium dioxide (TiO2) (CAS/EC numbers 13463-67-7/236-675-5, 1317-70-0/215-280- 1, 1317-80-2/215-282-2) - SCCS/1661/23 - Final document. HAL (Le Centre pour la Communication Scientifique Directe).

Fréry, Nadine, et al.. (2020). Biosurveillance des expositions professionnelles en Europe : le projet HBM4EU. Archives des maladies professionnelles et de médecine du travail/Archives des maladies professionnelles et de l'environnement. 81(1). 59–60. 1 indexed citations

Beronius, Anna, Laurent Bodin, Bas Bokkers, et al.. (2017). Evaluating the evidence for non-monotonic dose-response relationships: A systematic literature review and (re-)analysis of in vivo toxicity data in the area of food safety. Toxicology and Applied Pharmacology. 339. 10–23. 26 indexed citations

Bernauer, Ulrike, Laurent Bodin, Qasim Chaudhry, et al.. (2017). Opinion of the scientific committee on consumer safety (SCCS) – Final opinion on Polyaminopropyl Biguanide (PHMB) in cosmetic products - Submission III. Regulatory Toxicology and Pharmacology. 88. 328–329. 6 indexed citations

Bodin, L., Qasim Chaudhry, Pieter Jan Coenraads, et al.. (2017). Opinion of the scientific committee on consumer safety (SCCS) – Final version of the opinion on Ethylzingerone - ‘Hydroxyethoxyphenyl Butanone’ (HEPB) - Cosmetics Europe No P98 - in cosmetic products. Regulatory Toxicology and Pharmacology. 88. 330–331. 4 indexed citations

Beausoleil, Claire, Anna Beronius, Laurent Bodin, et al.. (2016). Review of non‐monotonic dose‐responses of substances for human risk assessment. EFSA Supporting Publications. 13(5). 32 indexed citations

Rousselle, Ch., V. des Portes, P. Berlier, & C. Mottolèse. (2014). Pineal region tumors: Clinical symptoms and syndromes. Neurochirurgie. 61(2-3). 106–112. 19 indexed citations

Angerer, J., et al.. (2011). Opinion on Toluene-2,5-diamine and its sulfate - COLIPA n° A5. 2 indexed citations

10.

Ourlin, Jean-Claude, et al.. (2011). Response of the THP-1 monocytic cells to the sensitizer dimethyl fumarate. Toxicology Letters. 205. S169–S170. 1 indexed citations

11.

Chabrier, Stéphane, et al.. (2009). Neurological Outcome and Risk of Recurrence Depending on the Anterior vs. Posterior Arterial Distribution in Children with Stroke. Neuropediatrics. 40(3). 126–128. 13 indexed citations

12.

Bedoin, Nathalie, et al.. (2006). Hemispheric lateralization of cognitive functions in children with centrotemporal spikes. Epilepsy & Behavior. 9(2). 268–274. 32 indexed citations

13.

Ansoborlo, É., et al.. (2003). Study of uranium transfer across the blood-brain barrier. Radiation Protection Dosimetry. 105(1-4). 243–245. 47 indexed citations

14.

Rousselle, Ch., et al.. (2003). Le régime cétogène à visée anti-épileptique : son utilisation chez 29 enfants épileptiques. Archives de Pédiatrie. 10(4). 300–306. 40 indexed citations

15.

Jourdan, C, et al.. (1993). [Hemodynamic study of acute neurogenic pulmonary edema in children].. PubMed. 48(11). 805–12. 4 indexed citations

16.

Claustrat, Bruno, et al.. (1987). [Dexamethasone suppression test in psychiatric pathology].. La Presse Médicale. 16(14). 669–71. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact